Atlas Trials

T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers

Clinical trial NCT04795479 · COMPLETED

Trial details

NCT number
NCT04795479
Sponsor
Corcept Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2021-01-22
Primary completion
2021-05-17
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.